Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-441
Closed -$45.4K 244
2023
Q3
$45.4K Buy
441
+2
+0.5% +$216 0.03% 98
2023
Q2
$50.6K Sell
439
-730
-62% -$82.9K 0.03% 95
2023
Q1
$124K Buy
1,169
+8
+0.7% +$864 0.08% 68
2022
Q4
$129K Buy
1,161
+8
+0.7% +$818 0.08% 64
2022
Q3
$99.3K Buy
1,153
+9
+0.8% +$803 0.07% 68
2022
Q2
$104K Buy
1,144
+9
+0.8% +$798 0.07% 66
2022
Q1
$93.2K Buy
1,135
+9
+0.8% +$710 0.06% 73
2021
Q4
$86.3K Buy
+1,126
New +$89.7K 0.06% 70

Other funds holding MRK

WFA Asset Management's MRK Position: Q4 2023 in Review

WFA Asset Management sold out of Merck (MRK) in Q4 2023, closing a stake of 441 shares — an estimated $45.4K sold.

WFA Asset Management first reported a position in MRK in Q4 2021 and held it in 8 quarters. The position peaked at $129K in Q4 2022. 3,434 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • WFA Asset Management reported no remaining Merck position as of Q4 2023 after selling out during the quarter.
  • WFA Asset Management sold 441 Merck shares in Q4 2023, an estimated $45.4K.
  • WFA Asset Management first reported a position in Merck in Q4 2021 and held it in 8 quarters.
  • WFA Asset Management's Merck position peaked at $129K in Q4 2022.
  • 3,434 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on WFA Asset Management's 13F filing for Q4 2023, filed 1 Feb 2024.